Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapses in patients with a systemic vasculitis

M Gordon1, R A Luqmani, D Adu

  • 1Department of Nephrology, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, UK.

The Quarterly Journal of Medicine
|December 1, 1993
PubMed
Summary

Systemic necrotizing vasculitis relapses are common, with varying rates and clinical features across subtypes. Long-term follow-up is crucial due to significant non-fatal relapse rates despite improved survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer's Disease mice.

Acta neuropathologica communications·2020
Same author

Multicenter Clinical Evaluation of the Revogene Strep A Molecular Assay for Detection of Streptococcus pyogenes from Throat Swab Specimens.

Journal of clinical microbiology·2020
Same author

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.

Current oncology (Toronto, Ont.)·2019
Same author

Responding to the marauding terror attack: the police perspective.

BMJ military health·2018
Same author

Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

[Topical therapy of the scalp].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Cyclophosphamide and steroids improve survival in systemic necrotizing vasculitis but do not guarantee a cure.
  • Data on relapse incidence, patterns, and outcomes in these diseases are limited.

Purpose of the Study:

  • To investigate the incidence, clinical features, and outcomes of relapses in patients with idiopathic necrotizing vasculitis.

Main Methods:

  • Retrospective study of 150 consecutive patients with idiopathic necrotizing vasculitis.
  • Classified patients into classical polyarteritis (CPAN), microscopic polyarteritis (MPA), Wegener's granulomatosis (WG), and limited Wegener's granulomatosis (LWG).
  • Analyzed relapse rates, time to relapse, and clinical characteristics of relapses.

Related Experiment Videos

Main Results:

  • Relapse rates varied: LWG (52%), WG (44%), CPAN (41.7%), MPA (25.4%).
  • Median time to relapse ranged from 18 months (LWG) to 42 months (WG).
  • Relapse features differed: CPAN/LWG relapses were similar/more aggressive, sometimes with new renal disease; MPA/WG relapses had less renal involvement.

Conclusions:

  • Systemic necrotizing vasculitis frequently relapses, with distinct patterns across subtypes.
  • Laboratory tests were unhelpful in predicting relapses.
  • The high cumulative non-fatal relapse rate underscores the necessity of long-term patient follow-up.